Zoetis Announces Agreement to Acquire VitalRADS, Accelerating Diagnostic Capabilities

Zoetis Inc. has announced its agreement to acquire VitalRADS, a veterinary teleradiology services platform.

Building on the partnership with VitalRADS that Zoetis announced in August 2025, this acquisition adds around-the-clock access to board-certified veterinary specialists through a cloud-based teleradiology platform. Integrating VitalRADS’ capabilities into Zoetis’ Global Diagnostics portfolio enhances Zoetis’ reference laboratory services, delivering AI-assisted report generation and quality assurance and advancing toward a more comprehensive end-to-end Virtual Reference Lab.

VitalRADS operates a suite of complementary services – teleradiology, mobile ultrasound, outpatient imaging, and cloud image storage. Through its teleradiology service, VitalRADS provides around-the-clock access to board-certified veterinary specialists who review digital radiographs, ECGs, CT scans, and MRI scans from all modalities across more than 25 species, delivering same-day results and two-hour STAT reads.

VitalRADS also provides a mobile ultrasound service in the Greater Houston and Greater Seattle regions, serving over 200 clinics by performing on-site scans with portable equipment and transmitting results for remote or on-site interpretation. In addition, VitalRADS operates an outpatient imaging center in Cypress, Texas that provides diagnostic imaging for canine and feline patients. Its cloud image storage platform, VitalPACS, offers a cohesive Picture Archiving and Communication System (PACS) that safeguards images and directly integrates with medical record systems, enabling continuous imaging operations with a secure, scalable solution for clinicians. The business supports more than 1,800 active customers – including corporate and independent practices and universities – and is recognized as an American College of Veterinary Radiology certified residency program.

“Through 24/7 access to world-class veterinary radiologists, cardiologists, neurologists, and dentists, VitalRADS helps veterinarians identify conditions faster, inform clinical decision-making, and guide treatment plans,” said Jamie Brannan, Executive Vice President and Chief Commercial Officer at Zoetis. “By strengthening our diagnostics ecosystem beyond in-vitro testing and building a more complete end-to-end Virtual Lab offering for our customers, we’re advancing our strategic pursuit of opportunities that unlock new sources of growth.”

“This is an important milestone for our team and a reflection of the value we provide to veterinary teams,” said Dr. Brian Poteet, Founder and Chief Executive Officer of VitalRADS. “We are proud of what we have accomplished and remain committed to delivering the high-quality service and support our clients rely on. As part of Zoetis’ Global Diagnostics portfolio, we look forward to continuing to advance diagnostic solutions and improve patient care.”

Advancing Zoetis’ Virtual Reference Laboratory and AI-Driven Diagnostics

The acquisition of VitalRADS expands Zoetis’ Virtual Reference Laboratory and complements Zoetis’ growing AI-driven Diagnostics offerings. The Zoetis Virtual Laboratory is an integrated support network of board-certified specialists paired with best-in-class AI, providing actionable insights to help veterinarians diagnose and treat with confidence. Zoetis’ Vetscan Imagyst and Vetscan Opticell platforms provide multiple testing applications in real-time at the point-of-care. VitalRADS brings specialist-led, AI-assisted workflows that streamline reporting, boosting productivity and quality. Its set of radiologist-centered tools includes auto-generated draft radiology reports from dictated findings, alongside an image-processing pipeline that supports quality review by flagging areas where model interpretation and radiologist findings diverge. These capabilities are powered by a robust clinical dataset and ongoing specialist feedback that support continuous improvement and insight generation.

Zoetis will partner closely with VitalRADS and its customers to ensure a seamless transition. The deal is expected to close in the third quarter of 2026, subject to customary closing conditions and regulatory approvals. Financial terms of the agreement are not being disclosed. Ropes & Gray LLP acted as legal counsel to VitalRADS, with Guggenheim Securities serving as financial adviser to VitalRADS. Fenwick & West LLP acted as legal counsel to Zoetis.